Immunization and SARS-CoV-2 antibody seroprevalence in a country with high vaccination coverage: Lessons from Chile
Gestores bibliográficos
Compartir
item.contributor.advisor
ORCID:
Journal Title
Journal ISSN
Volume Title
Publisher
item.page.isbn
item.page.issn
item.page.issne
item.page.doiurl
item.page.extent
11 p.
item.page.accessRights
Acceso abierto
item.page.other
item.page.references
Abstract
Objective: Chile is among the most successful nations worldwide in COVID-19 vaccine rollout. By December 31st, 2021, 84.1% of the population was fully vaccinated, and 56.1% received booster doses usin...
Description
item.page.coverage.spatial
item.page.sponsorship
Citation
Aguilera, X., González, C., Apablaza, M., Rubilar, P., Icaza, G., Ramírez-Santana, M., ... & Vial, P. (2022). Immunization and SARS-CoV-2 antibody seroprevalence in a country with high vaccination coverage: Lessons from Chile. Vaccines, 10(7), 1002
Keywords
COVID-19, Vaccine coverage, Sinovac CoronaVac, BNT162b2, AZD1222, Ad5-nCoV, cross sectional, population-based, Santiago, Talca, Coquimbo, La Serena, ELISA, sero-survey , Vaccine coverage , Sinovac CoronaVac , BNT162b2 , AZD1222 , Ad5-nCoV , Cross sectional , Population-based , ELISA , Sero-survey , Santiago , Talca , Coquimbo , La Serena
item.page.dc.rights
item.page.dc.rights.url
Estadísticas de uso
2 1,5 1 0,5 0
Septiembre 2025Octubre 2025Noviembre 2025Diciembre 2025Enero 2026Febrero 2026Marzo 2026